The American Pharmacists Association (APhA) has launched new and current training programs and resources to assist responders on the front lines of health care in staying safe and up to date with the latest research and practice guidance for the COVID-19 pandemic, it was reported on Tuesday.
APhA vice president, Professional Education Resources, Daniel Zlott, PharmD, BCOP, said, 'We are diligently working on behalf of pharmacists and patients to address the training needs of all as we face unprecedented times. Pharmacists can assist patients in a number of ways, including helping to increase the number of individuals who are able to be tested for COVID-19 and providing education to patients.'
The APhA's COVID-19 Specimen Collection Training guides pharmacists through the collection of nasopharyngeal swabs. The program will be adaptable to other testing methods once they become more widely available, such as nasal swabs, oral swabs, fingerstick tests, and other new technologies.
Privo Technologies doses first patient in first-in-human clinical trial of PRV131
Senhwa Biosciences signs clinical supply agreement with BeOne Medicines
InduPro secures strategic investment and collaboration with Sanofi to advance autoimmune therapy
Innovent Biologics reports first participant dosed in Phase 1 trial of IBI3011
Hemab Therapeutics announces positive Phase 2 multiple ascending dose study results for sutacimig
Cereno Scientific's Phase IIb trial of CS1 in PAH approved by US FDA
Champions Oncology expands bioanalytical services with new technology and leadership
Mirum Pharmaceuticals to acquire Bluejay Therapeutics for HDV treatment
Poolbeg Pharma trial to feature in major CRS research programme
PureTech clears key FDA milestone for Phase 3 development of deupirfenidone
Proteome Sciences wins third US biopharma contract for new clinical assay
Lundbeck reports results from long-term follow-up of epilepsy patients treated with bexicaserin
CARsgen Therapeutics presents CT0596 study data at 2005 ASH Annual Meeting
AsymBio starts commercial production at Shanghai Fengxian Manufacturing Base